Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TheraKine Ltd.
Hermosa Beach, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
TheraKine has developed a novel drug delivery platform that enables tunable, sustained release of drugs with durations from weeks to months. The company has shown promising preclinical results with naltrexone for alcohol and opioid dependence treatment, demonstrating sustained action for up to 6 months.
- Therapeutic areas
- OtherPsychiatry
- Modalities
- Biologics (monoclonal antibodies, antibody fragments, receptor antagonists)small molecules
- Industry
- Biotech
02
Partnerships
Rainbow Coral (joint venture partner)
Beyond the preview
Go deeper on TheraKine Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TheraKine Ltd..